Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)
Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding) Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Pavía Molina, José Oliver Martos, Begoña Alcamí Pertejo, Antonio Sola Gurpegui, María Isabel Hurtado Tamayo, Jesús Enjuanes Sánchez, Luis Fernández Fernández, Oscar Hurtado Guerrero, Isaac |
| description | Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding)
Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composiciones que comprenden dicha proteína. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2953479A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2953479A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2953479A13</originalsourceid><addsrcrecordid>eNqNisEKgkAQQL10iOof5ljQHtIiPIpodaiDVlcZbdSFbVbcIfDvw_ADOj147829z8MR2BrcJb1FmQ-aQVoC6QnlTSxjy6MsV7F9qjHXVIm2DOsrVq1mUtIjO4M_WQ5wsrYxBPfJ0hbYChhq0JgBSs0vzc1m6c1qNI5WExcepMk9PivqbEGuw4qYpEhyPzwE-2MY7YI_li-15UJn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)</title><source>esp@cenet</source><creator>Pavía Molina, José ; Oliver Martos, Begoña ; Alcamí Pertejo, Antonio ; Sola Gurpegui, María Isabel ; Hurtado Tamayo, Jesús ; Enjuanes Sánchez, Luis ; Fernández Fernández, Oscar ; Hurtado Guerrero, Isaac</creator><creatorcontrib>Pavía Molina, José ; Oliver Martos, Begoña ; Alcamí Pertejo, Antonio ; Sola Gurpegui, María Isabel ; Hurtado Tamayo, Jesús ; Enjuanes Sánchez, Luis ; Fernández Fernández, Oscar ; Hurtado Guerrero, Isaac</creatorcontrib><description>Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding)
Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composiciones que comprenden dicha proteína.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231113&DB=EPODOC&CC=ES&NR=2953479A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231113&DB=EPODOC&CC=ES&NR=2953479A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Pavía Molina, José</creatorcontrib><creatorcontrib>Oliver Martos, Begoña</creatorcontrib><creatorcontrib>Alcamí Pertejo, Antonio</creatorcontrib><creatorcontrib>Sola Gurpegui, María Isabel</creatorcontrib><creatorcontrib>Hurtado Tamayo, Jesús</creatorcontrib><creatorcontrib>Enjuanes Sánchez, Luis</creatorcontrib><creatorcontrib>Fernández Fernández, Oscar</creatorcontrib><creatorcontrib>Hurtado Guerrero, Isaac</creatorcontrib><title>Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)</title><description>Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding)
Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composiciones que comprenden dicha proteína.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNisEKgkAQQL10iOof5ljQHtIiPIpodaiDVlcZbdSFbVbcIfDvw_ADOj147829z8MR2BrcJb1FmQ-aQVoC6QnlTSxjy6MsV7F9qjHXVIm2DOsrVq1mUtIjO4M_WQ5wsrYxBPfJ0hbYChhq0JgBSs0vzc1m6c1qNI5WExcepMk9PivqbEGuw4qYpEhyPzwE-2MY7YI_li-15UJn</recordid><startdate>20231113</startdate><enddate>20231113</enddate><creator>Pavía Molina, José</creator><creator>Oliver Martos, Begoña</creator><creator>Alcamí Pertejo, Antonio</creator><creator>Sola Gurpegui, María Isabel</creator><creator>Hurtado Tamayo, Jesús</creator><creator>Enjuanes Sánchez, Luis</creator><creator>Fernández Fernández, Oscar</creator><creator>Hurtado Guerrero, Isaac</creator><scope>EVB</scope></search><sort><creationdate>20231113</creationdate><title>Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)</title><author>Pavía Molina, José ; Oliver Martos, Begoña ; Alcamí Pertejo, Antonio ; Sola Gurpegui, María Isabel ; Hurtado Tamayo, Jesús ; Enjuanes Sánchez, Luis ; Fernández Fernández, Oscar ; Hurtado Guerrero, Isaac</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2953479A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Pavía Molina, José</creatorcontrib><creatorcontrib>Oliver Martos, Begoña</creatorcontrib><creatorcontrib>Alcamí Pertejo, Antonio</creatorcontrib><creatorcontrib>Sola Gurpegui, María Isabel</creatorcontrib><creatorcontrib>Hurtado Tamayo, Jesús</creatorcontrib><creatorcontrib>Enjuanes Sánchez, Luis</creatorcontrib><creatorcontrib>Fernández Fernández, Oscar</creatorcontrib><creatorcontrib>Hurtado Guerrero, Isaac</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Pavía Molina, José</au><au>Oliver Martos, Begoña</au><au>Alcamí Pertejo, Antonio</au><au>Sola Gurpegui, María Isabel</au><au>Hurtado Tamayo, Jesús</au><au>Enjuanes Sánchez, Luis</au><au>Fernández Fernández, Oscar</au><au>Hurtado Guerrero, Isaac</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)</title><date>2023-11-13</date><risdate>2023</risdate><abstract>Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding)
Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composiciones que comprenden dicha proteína.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_ES2953479A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A52%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Pav%C3%ADa%20Molina,%20Jos%C3%A9&rft.date=2023-11-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2953479A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |